Does endogenous alpha-calcitonin gene-related peptide mitigate liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin A?
Endogenous alphaCGRP mitigates liver fibrosis in chronic hepatitis induced by repeated administration of Con A. alphaCGRP could be a useful therapeutic target for the treatment of chronic hepatitis.
Current Australian vaccination recommendations do not appear to match IPD epidemiology in WA; consideration should be given to lowering the age criterion for vaccination to 25 years for Indigenous and 60 years for non-Indigenous people. The new seven-valent conjugate vaccine may not adequately cover disease-causing serotypes in Indigenous children.